Part 7/8:
This policy shift could reshape the landscape of drug pricing in the U.S., potentially setting a precedent for international drug price negotiations. It aims not only to reduce costs but also to generate a more equitable healthcare system where lifesaving medications are accessible to all Americans.
Dr. Oz expressed optimism about the future, noting that the administration expects most drug manufacturers to cooperate eventually, covering a wide spectrum of therapies—from autoimmune disorders and cancer treatments to neurological diseases and weight management. The overall goal is to protect and advance American health innovations while making medications more affordable for everyday Americans.